Progenics Pharma (PGNX) Reports Q4 Loss of $0.04/Share

March 8, 2018 7:48 AM

Progenics Pharma (NASDAQ: PGNX) reported Q4 EPS of ($0.04), versus ($0.10) reported last year. Revenue for the quarter came in at $3.9 million, versus $4.65 million reported last year.

For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.


Earnings Guidance

Next Articles